# reload+after+2024-01-23 09:43:20.434915
address1§400 Crossing Boulevard
address2§3rd Floor
city§Bridgewater
state§NJ
zip§08807
country§United States
phone§908 947 3120
fax§908 947 3146
website§https://amneal.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
fullTimeEmployees§7600
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Chirag K. Patel', 'age': 56, 'title': 'Co-Founder, Co-CEO, President & Director', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1442314, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chintu  Patel R.Ph.', 'age': 51, 'title': 'Co-Founder, Co-CEO & Director', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 1456936, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Anastasios G. Konidaris', 'age': 56, 'title': 'Executive VP & CFO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 856379, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason B. Daly Esq.', 'age': 49, 'title': 'Senior VP, Chief Legal Officer & Corporate Secretary', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 782528, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Nikita  Shah', 'age': 44, 'title': 'Executive VP & Chief Human Resources Officer', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 757405, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew S. Boyer', 'age': 57, 'title': 'Executive VP & Chief Commercial Officer of Generics', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 1055366, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Anthony  DiMeo', 'title': 'Senior Director of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gregory  Sgammato', 'title': 'Senior Vice President of Corporate Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Pranav  Mehta', 'title': 'Senior VP of Strategic Sourcing & Supply Management', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sanjay Kumar Jain Ph.D.', 'title': 'President of India Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§7
compensationRisk§6
shareHolderRightsRisk§4
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.269
priceToSalesTrailing12Months§0.76944774
currency§USD
dateShortInterest§1701302400
forwardEps§0.58
pegRatio§-6.67
exchange§NMS
quoteType§EQUITY
shortName§Amneal Pharmaceuticals, Inc.
longName§Amneal Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1525699800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§0fcb03eb-c390-34ae-8733-d78649324217
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§5.5
targetMeanPrice§6.3
targetMedianPrice§6.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§1.082
grossMargins§0.35481998
ebitdaMargins§0.20963
trailingPegRatio§None
